PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A01 232,350 226,099 207,497 167,995 120,478 CD4 82,916 Neg Cont IFN-IL2-TNF+ 1 2 1 1 S N 8285 122054.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A01 232,350 226,099 207,497 167,995 120,478 CD4 82,916 Neg Cont IFN-IL2+TNF+ 2 2 1 1 S N 8285 122054.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A01 232,350 226,099 207,497 167,995 120,478 CD4 82,916 Neg Cont IFN+IL2-TNF- 1 5 1 1 S N 8285 122054.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A01 232,350 226,099 207,497 167,995 120,478 CD4 82,916 Neg Cont IFN+IL2-TNF+ 2 0 1 1 S N 8285 122054.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A01 232,350 226,099 207,497 167,995 120,478 CD4 82,916 Neg Cont IFN+IL2+TNF- 2 24 1 1 S N 8285 122054.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A01 232,350 226,099 207,497 167,995 120,478 CD4 82,916 Neg Cont IFN+IL2+TNF+ 3 1 1 1 S N 8285 122054.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A01 232,350 226,099 207,497 167,995 120,478 CD8 31,386 Neg Cont IFN-IL2-TNF- 0 31,378 1 1 S N 8285 122054.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A01 232,350 226,099 207,497 167,995 120,478 CD8 31,386 Neg Cont IFN-IL2-TNF+ 1 0 1 1 S N 8285 122054.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A01 232,350 226,099 207,497 167,995 120,478 CD8 31,386 Neg Cont IFN-IL2+TNF+ 2 0 1 1 S N 8285 122054.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A01 232,350 226,099 207,497 167,995 120,478 CD8 31,386 Neg Cont IFN+IL2-TNF- 1 5 1 1 S N 8285 122054.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A01 232,350 226,099 207,497 167,995 120,478 CD8 31,386 Neg Cont IFN+IL2-TNF+ 2 0 1 1 S N 8285 122054.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A01 232,350 226,099 207,497 167,995 120,478 CD8 31,386 Neg Cont IFN+IL2+TNF- 2 3 1 1 S N 8285 122054.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A01 232,350 226,099 207,497 167,995 120,478 CD8 31,386 Neg Cont IFN+IL2+TNF+ 3 0 1 1 S N 8285 122054.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A01 232,350 226,099 207,497 167,995 120,478 CD4 82,916 Neg Cont IFN-IL2+TNF- 1 19 1 1 S N 8285 122054.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A01 232,350 226,099 207,497 167,995 120,478 CD8 31,386 Neg Cont IFN-IL2+TNF- 1 0 1 1 S N 8285 122054.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A02 238,108 232,057 213,429 173,909 125,216 CD4 86,471 Neg Cont IFN-IL2-TNF- 0 86,409 2 1 S N 8286 122056.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A02 238,108 232,057 213,429 173,909 125,216 CD4 86,471 Neg Cont IFN-IL2-TNF+ 1 2 2 1 S N 8286 122056.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A02 238,108 232,057 213,429 173,909 125,216 CD4 86,471 Neg Cont IFN-IL2+TNF+ 2 2 2 1 S N 8286 122056.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A02 238,108 232,057 213,429 173,909 125,216 CD4 86,471 Neg Cont IFN+IL2-TNF- 1 14 2 1 S N 8286 122056.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A02 238,108 232,057 213,429 173,909 125,216 CD4 86,471 Neg Cont IFN+IL2-TNF+ 2 0 2 1 S N 8286 122056.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A02 238,108 232,057 213,429 173,909 125,216 CD4 86,471 Neg Cont IFN+IL2+TNF- 2 20 2 1 S N 8286 122056.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A02 238,108 232,057 213,429 173,909 125,216 CD4 86,471 Neg Cont IFN+IL2+TNF+ 3 0 2 1 S N 8286 122056.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A02 238,108 232,057 213,429 173,909 125,216 CD8 32,138 Neg Cont IFN-IL2-TNF- 0 32,132 2 1 S N 8286 122056.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A02 238,108 232,057 213,429 173,909 125,216 CD8 32,138 Neg Cont IFN-IL2-TNF+ 1 0 2 1 S N 8286 122056.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A02 238,108 232,057 213,429 173,909 125,216 CD8 32,138 Neg Cont IFN-IL2+TNF+ 2 0 2 1 S N 8286 122056.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A02 238,108 232,057 213,429 173,909 125,216 CD8 32,138 Neg Cont IFN+IL2-TNF- 1 3 2 1 S N 8286 122056.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A02 238,108 232,057 213,429 173,909 125,216 CD8 32,138 Neg Cont IFN+IL2-TNF+ 2 0 2 1 S N 8286 122056.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A02 238,108 232,057 213,429 173,909 125,216 CD8 32,138 Neg Cont IFN+IL2+TNF- 2 3 2 1 S N 8286 122056.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A02 238,108 232,057 213,429 173,909 125,216 CD8 32,138 Neg Cont IFN+IL2+TNF+ 3 0 2 1 S N 8286 122056.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A02 238,108 232,057 213,429 173,909 125,216 CD4 86,471 Neg Cont IFN-IL2+TNF- 1 24 2 1 S N 8286 122056.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-1 ICS025 Blinded 2006-03-30 00:00 Y Y A P1 1 A02 238,108 232,057 213,429 173,909 125,216 CD8 32,138 Neg Cont IFN-IL2+TNF- 1 0 2 1 S N 8286 122056.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B01 226,139 219,492 198,435 139,322 106,781 CD4 66,613 Neg Cont IFN-IL2-TNF- 0 66,558 1 1 S N 8287 122060.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B01 226,139 219,492 198,435 139,322 106,781 CD4 66,613 Neg Cont IFN-IL2-TNF+ 1 1 1 1 S N 8287 122060.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B01 226,139 219,492 198,435 139,322 106,781 CD4 66,613 Neg Cont IFN-IL2+TNF+ 2 3 1 1 S N 8287 122060.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B01 226,139 219,492 198,435 139,322 106,781 CD4 66,613 Neg Cont IFN+IL2-TNF- 1 15 1 1 S N 8287 122060.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B01 226,139 219,492 198,435 139,322 106,781 CD4 66,613 Neg Cont IFN+IL2-TNF+ 2 0 1 1 S N 8287 122060.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B01 226,139 219,492 198,435 139,322 106,781 CD4 66,613 Neg Cont IFN+IL2+TNF- 2 19 1 1 S N 8287 122060.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B01 226,139 219,492 198,435 139,322 106,781 CD4 66,613 Neg Cont IFN+IL2+TNF+ 3 0 1 1 S N 8287 122060.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B01 226,139 219,492 198,435 139,322 106,781 CD8 35,915 Neg Cont IFN-IL2-TNF- 0 35,907 1 1 S N 8287 122060.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B01 226,139 219,492 198,435 139,322 106,781 CD8 35,915 Neg Cont IFN-IL2-TNF+ 1 1 1 1 S N 8287 122060.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B01 226,139 219,492 198,435 139,322 106,781 CD8 35,915 Neg Cont IFN-IL2+TNF+ 2 1 1 1 S N 8287 122060.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B01 226,139 219,492 198,435 139,322 106,781 CD8 35,915 Neg Cont IFN+IL2-TNF- 1 4 1 1 S N 8287 122060.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B01 226,139 219,492 198,435 139,322 106,781 CD8 35,915 Neg Cont IFN+IL2-TNF+ 2 1 1 1 S N 8287 122060.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B01 226,139 219,492 198,435 139,322 106,781 CD8 35,915 Neg Cont IFN+IL2+TNF- 2 0 1 1 S N 8287 122060.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B01 226,139 219,492 198,435 139,322 106,781 CD8 35,915 Neg Cont IFN+IL2+TNF+ 3 0 1 1 S N 8287 122060.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B01 226,139 219,492 198,435 139,322 106,781 CD4 66,613 Neg Cont IFN-IL2+TNF- 1 17 1 1 S N 8287 122060.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B01 226,139 219,492 198,435 139,322 106,781 CD8 35,915 Neg Cont IFN-IL2+TNF- 1 1 1 1 S N 8287 122060.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B02 226,952 220,701 199,606 135,859 104,410 CD4 66,364 Neg Cont IFN-IL2-TNF- 0 66,326 2 1 S N 8288 122062.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B02 226,952 220,701 199,606 135,859 104,410 CD4 66,364 Neg Cont IFN-IL2-TNF+ 1 3 2 1 S N 8288 122062.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B02 226,952 220,701 199,606 135,859 104,410 CD4 66,364 Neg Cont IFN-IL2+TNF+ 2 1 2 1 S N 8288 122062.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B02 226,952 220,701 199,606 135,859 104,410 CD4 66,364 Neg Cont IFN+IL2-TNF- 1 2 2 1 S N 8288 122062.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B02 226,952 220,701 199,606 135,859 104,410 CD4 66,364 Neg Cont IFN+IL2-TNF+ 2 0 2 1 S N 8288 122062.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B02 226,952 220,701 199,606 135,859 104,410 CD4 66,364 Neg Cont IFN+IL2+TNF- 2 24 2 1 S N 8288 122062.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B02 226,952 220,701 199,606 135,859 104,410 CD4 66,364 Neg Cont IFN+IL2+TNF+ 3 1 2 1 S N 8288 122062.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B02 226,952 220,701 199,606 135,859 104,410 CD8 33,896 Neg Cont IFN-IL2-TNF- 0 33,892 2 1 S N 8288 122062.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B02 226,952 220,701 199,606 135,859 104,410 CD8 33,896 Neg Cont IFN-IL2-TNF+ 1 0 2 1 S N 8288 122062.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B02 226,952 220,701 199,606 135,859 104,410 CD8 33,896 Neg Cont IFN-IL2+TNF+ 2 0 2 1 S N 8288 122062.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B02 226,952 220,701 199,606 135,859 104,410 CD8 33,896 Neg Cont IFN+IL2-TNF- 1 4 2 1 S N 8288 122062.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B02 226,952 220,701 199,606 135,859 104,410 CD8 33,896 Neg Cont IFN+IL2-TNF+ 2 0 2 1 S N 8288 122062.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B02 226,952 220,701 199,606 135,859 104,410 CD8 33,896 Neg Cont IFN+IL2+TNF- 2 0 2 1 S N 8288 122062.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B02 226,952 220,701 199,606 135,859 104,410 CD8 33,896 Neg Cont IFN+IL2+TNF+ 3 0 2 1 S N 8288 122062.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B02 226,952 220,701 199,606 135,859 104,410 CD4 66,364 Neg Cont IFN-IL2+TNF- 1 7 2 1 S N 8288 122062.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-2 ICS026 Blinded 2006-03-30 00:00 Y Y A P1 2 B02 226,952 220,701 199,606 135,859 104,410 CD8 33,896 Neg Cont IFN-IL2+TNF- 1 0 2 1 S N 8288 122062.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C01 235,653 228,830 201,000 162,155 124,857 CD4 74,739 Neg Cont IFN-IL2-TNF- 0 74,688 1 1 S N 8289 122066.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C01 235,653 228,830 201,000 162,155 124,857 CD4 74,739 Neg Cont IFN-IL2-TNF+ 1 4 1 1 S N 8289 122066.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C01 235,653 228,830 201,000 162,155 124,857 CD4 74,739 Neg Cont IFN-IL2+TNF+ 2 0 1 1 S N 8289 122066.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C01 235,653 228,830 201,000 162,155 124,857 CD4 74,739 Neg Cont IFN+IL2-TNF- 1 9 1 1 S N 8289 122066.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C01 235,653 228,830 201,000 162,155 124,857 CD4 74,739 Neg Cont IFN+IL2-TNF+ 2 0 1 1 S N 8289 122066.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C01 235,653 228,830 201,000 162,155 124,857 CD4 74,739 Neg Cont IFN+IL2+TNF- 2 22 1 1 S N 8289 122066.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C01 235,653 228,830 201,000 162,155 124,857 CD4 74,739 Neg Cont IFN+IL2+TNF+ 3 2 1 1 S N 8289 122066.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C01 235,653 228,830 201,000 162,155 124,857 CD8 46,471 Neg Cont IFN-IL2-TNF- 0 46,463 1 1 S N 8289 122066.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C01 235,653 228,830 201,000 162,155 124,857 CD8 46,471 Neg Cont IFN-IL2-TNF+ 1 0 1 1 S N 8289 122066.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C01 235,653 228,830 201,000 162,155 124,857 CD8 46,471 Neg Cont IFN-IL2+TNF+ 2 0 1 1 S N 8289 122066.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C01 235,653 228,830 201,000 162,155 124,857 CD8 46,471 Neg Cont IFN+IL2-TNF- 1 4 1 1 S N 8289 122066.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C01 235,653 228,830 201,000 162,155 124,857 CD8 46,471 Neg Cont IFN+IL2-TNF+ 2 0 1 1 S N 8289 122066.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C01 235,653 228,830 201,000 162,155 124,857 CD8 46,471 Neg Cont IFN+IL2+TNF- 2 4 1 1 S N 8289 122066.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C01 235,653 228,830 201,000 162,155 124,857 CD8 46,471 Neg Cont IFN+IL2+TNF+ 3 0 1 1 S N 8289 122066.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C01 235,653 228,830 201,000 162,155 124,857 CD4 74,739 Neg Cont IFN-IL2+TNF- 1 14 1 1 S N 8289 122066.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C01 235,653 228,830 201,000 162,155 124,857 CD8 46,471 Neg Cont IFN-IL2+TNF- 1 0 1 1 S N 8289 122066.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C02 216,523 210,835 186,615 154,515 120,041 CD4 69,795 Neg Cont IFN-IL2-TNF- 0 69,750 2 1 S N 8290 122068.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C02 216,523 210,835 186,615 154,515 120,041 CD4 69,795 Neg Cont IFN-IL2-TNF+ 1 3 2 1 S N 8290 122068.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C02 216,523 210,835 186,615 154,515 120,041 CD4 69,795 Neg Cont IFN-IL2+TNF+ 2 0 2 1 S N 8290 122068.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C02 216,523 210,835 186,615 154,515 120,041 CD4 69,795 Neg Cont IFN+IL2-TNF- 1 10 2 1 S N 8290 122068.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C02 216,523 210,835 186,615 154,515 120,041 CD4 69,795 Neg Cont IFN+IL2-TNF+ 2 0 2 1 S N 8290 122068.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C02 216,523 210,835 186,615 154,515 120,041 CD4 69,795 Neg Cont IFN+IL2+TNF- 2 16 2 1 S N 8290 122068.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C02 216,523 210,835 186,615 154,515 120,041 CD4 69,795 Neg Cont IFN+IL2+TNF+ 3 0 2 1 S N 8290 122068.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C02 216,523 210,835 186,615 154,515 120,041 CD8 46,890 Neg Cont IFN-IL2-TNF- 0 46,880 2 1 S N 8290 122068.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C02 216,523 210,835 186,615 154,515 120,041 CD8 46,890 Neg Cont IFN-IL2-TNF+ 1 0 2 1 S N 8290 122068.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C02 216,523 210,835 186,615 154,515 120,041 CD8 46,890 Neg Cont IFN-IL2+TNF+ 2 0 2 1 S N 8290 122068.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C02 216,523 210,835 186,615 154,515 120,041 CD8 46,890 Neg Cont IFN+IL2-TNF- 1 5 2 1 S N 8290 122068.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C02 216,523 210,835 186,615 154,515 120,041 CD8 46,890 Neg Cont IFN+IL2-TNF+ 2 0 2 1 S N 8290 122068.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C02 216,523 210,835 186,615 154,515 120,041 CD8 46,890 Neg Cont IFN+IL2+TNF- 2 3 2 1 S N 8290 122068.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C02 216,523 210,835 186,615 154,515 120,041 CD8 46,890 Neg Cont IFN+IL2+TNF+ 3 0 2 1 S N 8290 122068.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C02 216,523 210,835 186,615 154,515 120,041 CD4 69,795 Neg Cont IFN-IL2+TNF- 1 16 2 1 S N 8290 122068.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-3 ICS027 Blinded 2006-03-30 00:00 Y Y A P1 3 C02 216,523 210,835 186,615 154,515 120,041 CD8 46,890 Neg Cont IFN-IL2+TNF- 1 2 2 1 S N 8290 122068.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-4 ICS028 Blinded 2006-03-30 00:00 Y Y A P1 4 D01 250,822 242,632 211,457 156,904 115,695 CD4 86,751 Neg Cont IFN-IL2-TNF- 0 86,676 1 1 S N 8291 122072.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-4 ICS028 Blinded 2006-03-30 00:00 Y Y A P1 4 D01 250,822 242,632 211,457 156,904 115,695 CD4 86,751 Neg Cont IFN-IL2-TNF+ 1 9 1 1 S N 8291 122072.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-4 ICS028 Blinded 2006-03-30 00:00 Y Y A P1 4 D01 250,822 242,632 211,457 156,904 115,695 CD4 86,751 Neg Cont IFN-IL2+TNF+ 2 7 1 1 S N 8291 122072.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-4 ICS028 Blinded 2006-03-30 00:00 Y Y A P1 4 D01 250,822 242,632 211,457 156,904 115,695 CD4 86,751 Neg Cont IFN+IL2-TNF- 1 12 1 1 S N 8291 122072.fcs
PV1 FH L02-060403-PV1-R1 L02-060403-PV1-R1-4 ICS028 Blinded 2006-03-30 00:00 Y Y A P1 4 D01 250,822 242,632 211,457 156,904 115,695 CD4 86,751 Neg Cont IFN+IL2-TNF+ 2 0 1 1 S N 8291 122072.fcs